Literature DB >> 18541102

Contact allergy to glucocorticosteroids in patients with chronic venous leg ulcers, atopic dermatitis and contact allergy.

Maria Zmudzinska1, Magdalena Czarnecka-Operacz, Wojciech Silny.   

Abstract

The aim of the study was to assess the prevalence of contact allergy to glucocorticosteroids in patients with chronic venous leg ulcers (CVLU), atopic dermatitis (AD) and contact dermatitis (CD), and in a group of healthy individuals; and to estimate differences among these patient groups. Patch tests with the European standard series, antibiotics, glucocorticosteroid contact allergy screening markers and ointment vehicles were performed in a population of 140 patients. Positive patch tests results were recorded in 80% and contact allergy to glucocorticosteroids in 40% of CVLU patients. In the group of AD patients, the respective figures were 30% and 3%. In the group of CD patients, allergic type of disease was detected in 80% and positive patch tests for glucocorticosteroids in 20% of patients. In healthy individuals, allergic contact reaction was observed in 17% of cases. Statistically significant differences among patient groups were found according to the prevalence of contact allergy, polyvalent allergy and contact allergy to glucocorticosteroids. We suggest that glucocorticosteroid contact allergy should be considered as a crucial clinical problem in patients with inflammatory dermatoses like CVLU, AD and CD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18541102

Source DB:  PubMed          Journal:  Acta Dermatovenerol Croat        ISSN: 1330-027X            Impact factor:   1.256


  4 in total

Review 1.  Treatment of Eczema: Corticosteroids and Beyond.

Authors:  Melanie Chong; Luz Fonacier
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

2.  Prevalence and trend of allergen sensitization in patients with a diagnosis of stasis dermatitis referred for patch testing, North American contact dermatitis group data, 2001-2016.

Authors:  Jonathan I Silverberg; Alexander Hou; Erin M Warshaw; Howard I Maibach; Donald V Belsito; Joel G DeKoven; Kathryn A Zug; James S Taylor; Denis Sasseville; Anthony F Fransway; Vincent A DeLeo; Melanie D Pratt; Margo J Reeder; Amber R Atwater; Joseph F Fowler; Matthew J Zirwas; James G Marks
Journal:  Arch Dermatol Res       Date:  2021-11-08       Impact factor: 3.033

3.  Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.

Authors:  Omid Sadeghi; Alireza Milajerdi; Seyed Davar Siadat; Seyed Ali Keshavarz; Ali Reza Sima; Homayoon Vahedi; Peyman Adibi; Ahmad Esmaillzadeh
Journal:  Trials       Date:  2020-06-23       Impact factor: 2.279

4.  Contact allergy in the population of patients with chronic inflammatory dermatoses and contact hypersensitivity to corticosteroids.

Authors:  Marek Kot; Jarosław Bogaczewicz; Beata Kręcisz; Anna Woźniacka
Journal:  Postepy Dermatol Alergol       Date:  2017-05-29       Impact factor: 1.837

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.